Fibrosis: all 1,270 studies
Page 9 of 13. Open to participants first (276), then studies with results posted, then the rest; newest registration first within each.
- Evaluation of the Role of Plasma Biomarkers in the Development of Decompensation in Patients With Cirrhosis .Status unknownNCT03084185
- Mutational Landscape in Hepatocellular CarcinomaCompletedNCT03071458
- Dextran, a Plasma Expander, Offers New Hope for Patients With Decompensated Liver Cirrhosis and Acute Kidney InjuryCompletedNCT03070353Phase 2/3
- Carvedilol, Endoscopic Variceal Ligation or Combination of Both for Prevention of First Variceal Bleed in Child's B & C CirrhosisStatus unknownNCT03069339Not applicable
- Two Strategies of Primary Prophylaxis of Spontaneous Bacterial Peritonitis in Severe Cirrhotic Patients With AscitesCompletedNCT03069131Phase 3
- S-Shearwave Elastography for Assessment of Hepatic FibrosisCompletedNCT03047707Not applicable
- Prophylactic Use of Antibiotics in Endoscopic Injection of Tissue Adhesive in Gastric VaricesStatus unknownNCT03045783Not applicable
- Oral Gut Liver Axis in CirrhosisCompletedNCT03030820Not applicable
- Validation in a Non-targeted Population of Single Ultrasound Doppler Signs of Liver FibrosisStatus unknownNCT03027921Not applicable
- PEriToneal Catheter Versus Repeated Paracentesis for Ascites in CirrhosisTerminatedNCT03027635Not applicable
- Efficacity and Safety of Tranexamic Acid in Cirrhotic Patients Presenting With Acute Upper Gastrointestinal BleedingStatus unknownNCT03023189Phase 4
- Fecal Microbiota Transplantation for Decompensated CirrhosisStatus unknownNCT03014505Phase 1/2
- Amniotic Membrane Wrapping and Tenolysis Versus Tenolysis Alone for Treatment of Tendon Adhesions of the Hand/WristStatus unknownNCT03013582Not applicable
- RNA and Heat Shock Protein Biomarkers in Radiation-induced Fibrosis in Breast CancerCompletedNCT03000764Not applicable
- Rifaximin in Patients With Gastroesophageal Variceal BleedingCompletedNCT02991612Not applicable
- The Utility of Thromboelastography in Cirrhotic Patients Undergoing Endoscopic ProceduresTerminatedNCT02990273Not applicable
- Use of the French Healthcare Insurance DatabaseCompletedNCT02983968
- Doppler Ultrasound Hepatic Vein Waveform as a Non-invasive Tool in the Assessment of Severity of Portal HypertensionStatus unknownNCT02975323Phase 3
- Exploring Biomarkers Predicting the Outcome of Acute-on-chronic Liver FailureCompletedNCT02965560
- Efficacy of Rifaximin in Treatment of Cirrhotic Gastroesophageal Variceal BleedingStatus unknownNCT02964195Not applicable
- ST2 for the Management of Heart Failure - STADE-HFCompletedNCT02963272Not applicable
- Evaluating the Effect of Spironolactone on Hypertrophic CardiomyopathyStatus unknownNCT02948998Phase 4
- Comparison of EUS-Guided Liver Biopsy With Percutaneous Liver BiopsyWithdrawnNCT02947516Not applicable
- Mindfulness and Support Group to Improve Patient and Caregiver Burden in CirrhosisCompletedNCT02944643Not applicable
- Bariatric Embolization of Arteries in Obese Patients With HCC to Allow Salvage Liver TransplantationSuspendedNCT02935478Not applicable
- Feeding Behavior and Taste Sensitivity Before and After Liver or Renal TransplantationStatus unknownNCT02931812
- Integrating Palliative Care for Patients With Idiopathic Pulmonary Fibrosis and Their CaregiversCompletedNCT02929017Not applicable
- Early Precise Diagnosis and Intervention of CPT Based on a Noninvasive 3D-vHPSStatus unknownNCT02925975Phase 4
- Extracellular RNA Markers of Liver Disease and CancerTerminatedNCT02908048
- Spironolactone on Fibrosis Progrssion-Portal Hypertension(FP-PH)in CirrhosisCompletedNCT02907749Phase 4
- The Prevalence and Severity of HCV Infection in Thalassemia Major and Thalassemia Intermedia in Siriraj HospitalCompletedNCT02904252
- Clinical Benefit of Spa Care on Severe Radiation-induced Fibrosis After Postoperative Radiotherapy for Breast CancerStatus unknownNCT02898376Phase 3
- Transitional Care Interventions for Patients With Cirrhosis Post-TIPSStatus unknownNCT02877953Not applicable
- Anti-E1E2 Antibodies (D32.10 Epitope-binding Antibodies) and HCV Triple TherapyCompletedNCT02877199
- Regression of Liver Fibrosis After Daclatasvir and Asunaprevir TreatmentStatus unknownNCT02865369
- Trial of Faecal Microbiota Transplantation in CirrhosisCompletedNCT02862249Phase 3
- Evaluation of Hepatic Function Using Gadoxetic Acid Enhanced MRICompletedNCT02854371Phase 4
- Comparison of Biannual Ultrasonography and Annual Unenhanced Magnetic Resonance Imaging for HCC SurveillanceStatus unknownNCT02854241Not applicable
- Transfer Factor Efficacy in the Management of Cirrhosis-associated Immune DysfunctionWithdrawnNCT02837939Phase 2/3
- Observational Study on Patients With Baclofen Treatment for Alcohol-dependence in FranceCompletedNCT02835365
- Examination the Ability to Early Diagnose HCC by Combining Three Biomarkers Technology Developed by WAKO, And Their Relevance to Cirrhotic of Patients With Various Backgrounds and the Israeli Population.Status unknownNCT02826005Not applicable
- Nalmefene in Patients With Alcoholic Compensated Cirrhosis for the Treatment of Alcohol Dependence.WithdrawnNCT02824354Phase 3
- Metabolic Effects of Furosemide +HSS in Refractory AscitesCompletedNCT02821377Phase 2
- Follow-up Strategy of Chronic Hepatitis B for Early Detection and Diagnosis of Hepatocellular Carcinoma: A Randomized Control TrialStatus unknownNCT02817685
- The Influence Cirrhosis of the Liver on the Coronary Re-stenosis (LTX- Stent Study)WithdrawnNCT02809248Not applicable
- Safety and Efficacy of Bemiparin in the Prevention of Thrombotic Events in Hospitalized Cirrhotic PatientsStatus unknownNCT02802605Phase 3
- Magnetic Resonance Imaging and FibrosisCompletedNCT02790008
- Donor Specific HLA Alloantibodies in Liver TransplantationActive, not recruitingNCT02784080
- B-mode Ultrasound Imaging in Detecting Early Liver CancerCompletedNCT02774161Not applicable
- Cameroon Baptist Convention Health Board Chronic Hepatitis B Cohort StudyCompletedNCT02766933
- Impact of Antiviral Therapy on Gastroesophageal Varices.CompletedNCT02758509
- Assessment of Coagulation Abnormalities in Acute on Chronic Liver Failure Patients Using ThromboelastographyStatus unknownNCT02757170Phase 4
- Comparison of Standard Dose Versus Once a Day Intravenous Albumin in Spontaneous Bacterial PeritonitisCompletedNCT02756741Not applicable
- The Effect of Branched-chain Amino Acid on the Improvement of Serum Albumin Level in Cirrhotic Patients With AscitesStatus unknownNCT02755701Phase 4
- Safety and Tolerability of PBI-4050 and Its Effects on the Biomarkers in Subjects With Alström SyndromeCompletedNCT02739217Phase 2
- Correlation of Hepatitis C, Alcoholic Liver Disease, and Renal Failure With Hyperfibrinolysis in Liver FailureCompletedNCT02737345
- The Alfred Step Test Exercise Protocol (A-STEP), for Adults With Cystic Fibrosis.CompletedNCT02717650Not applicable
- Sofosbuvir, Ledipasvir, Ribavirin for Hepatitis C Cirrhotics, Genotype 1CompletedNCT02705534Phase 3
- Isolation of Pulmonary Veins With the Aid of Magnetic Resonance ImagingCompletedNCT02698631Phase 4
- Efficiency and Safety of Prophylactic Use of Antibiotics in Endoscopic Injection of Tissue Adhesive in Gastric VaricesStatus unknownNCT02693951Not applicable
- Emricasan, a Caspase Inhibitor, for Evaluation in Subjects With Non-Alcoholic Steatohepatitis (NASH) FibrosisCompletedNCT02686762Phase 2
- ACE-inhibitors in Extracapillary GlomerulonephritisStatus unknownNCT02682459Phase 2
- Skin/Soft Tissue Elasticity in Head and Neck Cancer Survivors With Lymphedema and FibrosisCompletedNCT02676752
- To Evaluate the Efficacy and Safety of Rapamycin for Crohn's Disease-related StrictureStatus unknownNCT02675153Not applicable
- Ultrasonography SWE for Hepatic Fibrosis EvaluationCompletedNCT02673411
- Breath and Blood Ammonia Response to an Oral Protein ChallengeCompletedNCT02650245Not applicable
- Multicenter Prospective Randomized Trial of the Effect of Rivaroxaban on Survival and Development of Complications of Portal Hypertension in Patients With CirrhosisStatus unknownNCT02643212Phase 3
- To Assess the Efficacy of Granulocyte Colony Stimulating Factor Versus Standard Medical Therapy in Patients of Decompensated CirrhosisCompletedNCT02642003Phase 3
- The Effect of Hepatic Vein Pressure Gradient(HVPG)-Guided Therapy in Cirrhotic Patients With Esophagogastric VaricesStatus unknownNCT02638415Phase 4
- Fecal Transplant in Recurrent Hepatic EncephalopathyCompletedNCT02636647Phase 1
- High Fluence Light Emitting Diode-Red Light (LED-RL) in Human SkinCompletedNCT02630303Phase 1
- Interferon/Ribavirin-Free Sofosbuvir Based Treatment (AURIC)CompletedNCT02628717
- Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver FunctionTerminatedNCT02626312Phase 1
- Evaluation of Serum-Derived Bovine Immunoglobulin Protein Isolate in Subjects With Decompensated Cirrhosis With AscitesCompletedNCT02608658Not applicable
- Imaging FIB ONE in the Human Lung Using EndomicroscopyCompletedNCT02604862Early Phase 1
- Supplemental Corticosteroids in Cirrhotic Hypotensive Patients With Suspicion of SepsisTerminatedNCT02602210Phase 3
- Effects of Harvoni in Patients With Decompensated Cirrhosis Due to Hepatitis C Genotype 1 InfectionCompletedNCT02597166Phase 3
- Sofosbuvir, Daclatasvir, Ribavirin for Hepatitis C Virus (HCV) CirrhoticsCompletedNCT02596880Phase 3
- Administration of Rifaximin to Improve Liver Regeneration and Outcome Following Major Liver ResectionTerminatedNCT02555293Phase 2
- Cardiox Liver Function Test Pivotal TrialWithdrawnNCT02552901Phase 3
- Valvular Aortic Stenosis: Study of Myocardiac Fibrosis by Magnetic Resonance ImageryCompletedNCT02551588
- Prospective Evaluation of HIV Patients Using Non-invasive Methods for Estimation of Liver Fibrosis and SteatosisStatus unknownNCT02542020
- Comparison of Covered and Bare Stent in TIPSCompletedNCT02540382Not applicable
- Efficacy of Delayed Enhancement MRI-Guided Ablation vs Conventional Catheter Ablation of Atrial FibrillationCompletedNCT02529319Not applicable
- To Determine the Role of Prokinetics in Feed Intolerance in Critically Ill CirrhosisCompletedNCT02528760Not applicable
- Macrophages, Portal Hypertension, and Liver Function During AbbVie Treatment of Chronic Hepatitis CCompletedNCT02526641
- Epigenetic Determinants of Peritoneal FibrosisCompletedNCT02513615
- Surrogate Markers of Portal PressureCompletedNCT02508298Not applicable
- The Study of Spectrum of Sleep Disorders in Cirrhotic Patients and the Efficacy of Zolpidem in Cirrhotic Patients With InsomniaCompletedNCT02484963Not applicable
- Evaluation of Intestinal Permeability in Cirrhotic Patients Before and After Treatment With Non-selective Beta Blocker (Propranolol)Status unknownNCT02484573Not applicable
- Thrombin Generation Test in Patient With Liver CirrhosisCompletedNCT02484534
- Hepatic Fibrosis Assessment Using Multiparametric Magnetic Resonance ImagingCompletedNCT02480972Not applicable
- Prognostic Value of Measuring DsAz by MRI in Cirrhotic Patients on Prophylactic Treatment With β Blocker (AzyMR)CompletedNCT02475122Not applicable
- To Study and Compare the Clinical Course and Development of Organ Failure in Severe Acute Hepatitis Without Ascites, Non-cirrhotic and Cirrhotic Patients With Ascites [Acute on Chronic Liver Failure] and Acute Deterioration of Previously Decompensated Cirrhosis.WithdrawnNCT02465619
- The Cirrhosis Outpatient Optimization, Readmission & Safety StudyTerminatedNCT02457988Early Phase 1
- Granulocyte Colony Stimulating Factor And Growth Hormone In Cirrhosis Of Liver: An Open Label StudyCompletedNCT02451033Phase 2/3
- Transient Elastography to Assess Liver Fibrosis and Portal Hypertension in HCV Cirrhotic Patients Treated With New Antiviral Drugs (SPLEEN-C)CompletedNCT02439567Not applicable
- Biomarkers of Liver FibrosisTerminatedNCT02438917
- Effect of Transjugular Intrahepatic Portosystemic Shunt on Gut Microbiota in Cirrhotic PatientsStatus unknownNCT02427906
- Sugammadex Versus Neostigmine in Patients With Liver Cirrhosis Undergoing Liver ResectionCompletedNCT02414880Phase 4